Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (15 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Nalak Das headshot

5 Top Value Stocks to Buy in a Volatile April

Volatility is likely to persist in April as the panoptic impact of the coronavirus outbreak is yet to be realized in the United States and globally.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Has DaVita (DVA) Outpaced Other Medical Stocks This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

DaVita HealthCare (DVA) Stock Moves -0.46%: What You Should Know

DaVita HealthCare (DVA) closed the most recent trading day at $76.06, moving -0.46% from the previous trading session.

Top Ranked Growth Stocks to Buy for March 31st

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 31st

Here's Why You Should Invest in DaVita (DVA) Stock Right Now

DaVita (DVA) continues to gain traction from strong international foothold, strategic buyout of dialysis centers and DaVita Kidney Care.

Zacks.com featured highlights include: ITOCHU, Am??rica M??vil, Donegal, DaVita and The Cardinal Health

Zacks.com featured highlights include: ITOCHU, Am??rica M??vil, Donegal, DaVita and The Cardinal Health

Nilanjan Choudhury headshot

Use Relative Price Strength to Survive the Coronavirus Hysteria

Want to try an out-of-the-box approach to earn handsome returns in the time of coronavirus? Tap these stocks with explosive relative price strength.

DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know

DaVita HealthCare (DVA) closed at $75.27 in the latest trading session, marking a +0.19% move from the prior day.

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

DaVita HealthCare (DVA) Down 12.2% Since Last Earnings Report: Can It Rebound?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Top Ranked Growth Stocks to Buy for March 10th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 10th

CVS Health's Latest Alliances to Fortify Kidney-Care Business

With a growing incidence of chronic kidney diseases and end-stage renal failure in the United States, CVS Health's (CVS) new partnerships seem to be strategic.

Time to Focus on DaVita (DVA) for Strong Earnings Growth Potential

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider DaVita (DVA).

Why DaVita (DVA) Stock Might be a Great Pick

DaVita (DVA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Has DaVita (DVA) Outpaced Other Medical Stocks This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

Top Ranked Growth Stocks to Buy for February 27th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 27th

Why DaVita (DVA) Could Be an Impressive Growth Stock

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider DaVita (DVA).

Why DaVita (DVA) Could Be Positioned for a Surge

DaVita (DVA) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Zacks.com featured highlights include: Tempur Sealy International, Twin River Worldwide, Rite Aid, DaVita and United Therapeutics

Zacks.com featured highlights include: Tempur Sealy International, Twin River Worldwide, Rite Aid, DaVita and United Therapeutics

Top Ranked Growth Stocks to Buy for February 19th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 19th

Nilanjan Choudhury headshot

5 Stocks in Focus on Remarkable Relative Price Strength

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma

The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma